Literature DB >> 22281707

Cystinuria: mechanisms and management.

Donna J Claes1, Elizabeth Jackson2.   

Abstract

Cystinuria is a relatively uncommon cause of pediatric stone disease, but has significant morbidity if not properly controlled because of its significant stone recurrence rate. Cystinuria is caused by the inability of the renal tubules to reabsorb filtered cystine, which is poorly soluble at a typical urine pH <7. Although many advances have been made in the understanding of the genetic and physiological basis of cystinuria, the cornerstones of treatment still involve stone prevention with dietary measures and pharmacological therapy, coupled with surgical interventions for stone removal. Pharmacological treatments can carry significant side effects that must be monitored and can limit therapy as well as impede compliance. Most patients will require surgical intervention for stone removal, although compliance with prevention strategies reduces the need for intervention.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281707     DOI: 10.1007/s00467-011-2092-6

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  36 in total

1.  The effect of penicillamine on vitamin B6 function in man.

Authors:  P C Rumsby; D M Shepherd
Journal:  Biochem Pharmacol       Date:  1981-11-15       Impact factor: 5.858

Review 2.  Cystinuria in childhood and adolescence: recommendations for diagnosis, treatment, and follow-up.

Authors:  Thomas Knoll; Antonia Zöllner; Gunnar Wendt-Nordahl; Maurice Stephan Michel; Peter Alken
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

3.  Medical treatment of cystinuria: critical reappraisal of long-term results.

Authors:  F Barbey; D Joly; P Rieu; A Méjean; M Daudon; P Jungers
Journal:  J Urol       Date:  2000-05       Impact factor: 7.450

4.  Crystal growth inhibitors for the prevention of L-cystine kidney stones through molecular design.

Authors:  Jeffrey D Rimer; Zhihua An; Zina Zhu; Michael H Lee; David S Goldfarb; Jeffrey A Wesson; Michael D Ward
Journal:  Science       Date:  2010-10-15       Impact factor: 47.728

5.  Cystinuria in children: distribution and frequencies of mutations in the SLC3A1 and SLC7A9 genes.

Authors:  Elke Botzenhart; Udo Vester; Christa Schmidt; Albrecht Hesse; Marc Halber; Carsten Wagner; Florian Lang; Peter Hoyer; Klaus Zerres; Thomas Eggermann
Journal:  Kidney Int       Date:  2002-10       Impact factor: 10.612

Review 6.  New horizons in the management of patients with cystinuria.

Authors:  Hans-Göran Tiselius
Journal:  Curr Opin Urol       Date:  2010-03       Impact factor: 2.309

Review 7.  Cystinuria.

Authors:  Aditya Mattoo; David S Goldfarb
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

8.  Extracorporeal shock wave lithotripsy in prepubertal children: 22-year experience at a single institution with a single lithotriptor.

Authors:  Ezekiel H Landau; Ofer Z Shenfeld; Dov Pode; Amos Shapiro; Shimon Meretyk; Giora Katz; Ran Katz; Mordechai Duvdevani; Benjamin Hardak; Helio Cipele; Guy Hidas; Vladimir Yutkin; Ofer N Gofrit
Journal:  J Urol       Date:  2009-08-18       Impact factor: 7.450

Review 9.  Adverse effects profile of sulfhydryl compounds in man.

Authors:  I A Jaffe
Journal:  Am J Med       Date:  1986-03       Impact factor: 4.965

10.  Cystinuria in children and young adults: success of monitoring free-cystine urine levels.

Authors:  Luca Dello Strologo; Chiara Laurenzi; Antonia Legato; Anna Pastore
Journal:  Pediatr Nephrol       Date:  2007-08-11       Impact factor: 3.714

View more
  33 in total

Review 1.  Cystinuria: genetic aspects, mouse models, and a new approach to therapy.

Authors:  Amrik Sahota; Jay A Tischfield; David S Goldfarb; Michael D Ward; Longqin Hu
Journal:  Urolithiasis       Date:  2018-12-04       Impact factor: 3.436

2.  CUA guideline on the evaluation and medical management of the kidney stone patient - 2016 update.

Authors:  Marie Dion; Ghada Ankawi; Ben Chew; Ryan Paterson; Nabil Sultan; Patti Hoddinott; Hassan Razvi
Journal:  Can Urol Assoc J       Date:  2016-11-10       Impact factor: 1.862

3.  Management of Hematuria in Children.

Authors:  O N Ray Bignall; Bradley P Dixon
Journal:  Curr Treat Options Pediatr       Date:  2018-06-14

Review 4.  Diagnosis and management of non-calcium-containing stones in the pediatric population.

Authors:  Saritha Ranabothu; Ari P Bernstein; Beth A Drzewiecki
Journal:  Int Urol Nephrol       Date:  2018-05-30       Impact factor: 2.370

5.  Cystinuria in a patient with 19q12q13.1 deletion.

Authors:  Teresa de Rojas; Cristina Aparicio; Carmen de Lucas; Beatriz Martinez; Belén Gil-Fournier; Soraya Ramiro-León
Journal:  CEN Case Rep       Date:  2015-09-19

6.  l-Cystine Diamides as l-Cystine Crystallization Inhibitors for Cystinuria.

Authors:  Longqin Hu; Yanhui Yang; Herve Aloysius; Haifa Albanyan; Min Yang; Jian-Jie Liang; Anthony Yu; Alexander Shtukenberg; Laura N Poloni; Vladyslav Kholodovych; Jay A Tischfield; David S Goldfarb; Michael D Ward; Amrik Sahota
Journal:  J Med Chem       Date:  2016-07-26       Impact factor: 7.446

Review 7.  Tubular and genetic disorders associated with kidney stones.

Authors:  Nilufar Mohebbi; Pietro Manuel Ferraro; Giovanni Gambaro; Robert Unwin
Journal:  Urolithiasis       Date:  2016-11-28       Impact factor: 3.436

8.  Early Recognition and Management of Rare Kidney Stone Disorders.

Authors:  Boss Goldstein; David S Goldfarb
Journal:  Urol Nurs       Date:  2017 Mar-Apr

9.  Synergistic mutations in SLC3A1 and SLC7A9 leading to heterogeneous cystinuria phenotypes: pitfalls in the diagnostic workup.

Authors:  Sebastian Kummer; Andreas Venghaus; Andrea Schlune; Barbara Leube; Thomas Eggermann; Ute Spiekerkoetter
Journal:  Pediatr Nephrol       Date:  2013-09-19       Impact factor: 3.714

Review 10.  How should patients with cystine stone disease be evaluated and treated in the twenty-first century?

Authors:  Kim Hovgaard Andreassen; Katja Venborg Pedersen; Susanne Sloth Osther; Helene Ulrik Jung; Søren Kissow Lildal; Palle Joern Sloth Osther
Journal:  Urolithiasis       Date:  2015-11-27       Impact factor: 3.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.